Casey: I too wonder if it's getting overdiagnosed. It's given GI's a new reason to push EGDs for speculative reasons. An...

Hey Doc, I was looking back at one of your old articles on $RCPT Receptos., b/c I have a GI appt coming up for an EGD. I...

A quick note to bring to reader attention Coherus Biosciences, upgraded this am by Citigroup, which sees about 50 percen...

bconway on Saving Jack Kerouac / Feb 16, 2:31pm

Dr. KSS, a friend of mine who is a patent lawyer has been talking about Coherus bioscience CHRS which describes itself a...

I am glad some here have made money on $CTRV. And I'd back up the truck, and drive off and never look back. Take the mon...

Dr KSS Re CHRS. Coherus (CHRS) is up more that 60% since it's IPO in November including 12% today. It looks like it i...

To Frank Belknap: and this may apply to others.I encourage you to consider, when choosing biotechs to be in, to invo...

I read with interest the recent discussion here of 3 recent IPO's SPHS, Sophiris, CHRS, Coherus, and XENE, Xenon. I do ...

From JPM. Its a lot longer if you guys want me to post.Investment Thesis Coherus BioSciences (CHRS) Overweigh...

The Credit Suisse report is 81 pages of information regarding Biosimilars vs. Biologics. A number of power points that a...

Let me put this out there as a prologue for discussing Coherus, which I need to digest but which may well be worth getti...

@Dr. KSS: There´s a German biosimilars stock, too, it´s called Formycon and this one had also a huge run lately. Nonet...

Coherus was backed by KKR before going public -- the rush of analyst reports all at once may be at least partly due to t...

Here you go Doc- CHRS Coherus Biosciences Inc., is a biopharmaceutical company. "The Company develops biosimilar thera...

A company called Coherus is getting lots of new analyst buy rec coverage. If anyone has some time, maybe dig into this o...